These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


265 related items for PubMed ID: 23324595

  • 1. Grey matter damage in multiple sclerosis: a pathology perspective.
    Klaver R, De Vries HE, Schenk GJ, Geurts JJ.
    Prion; 2013; 7(1):66-75. PubMed ID: 23324595
    [Abstract] [Full Text] [Related]

  • 2. Grey matter pathology in clinically early multiple sclerosis: evidence from magnetic resonance imaging.
    Chard D, Miller D.
    J Neurol Sci; 2009 Jul 15; 282(1-2):5-11. PubMed ID: 19201002
    [Abstract] [Full Text] [Related]

  • 3. Regional variations in the extent and pattern of grey matter demyelination in multiple sclerosis: a comparison between the cerebral cortex, cerebellar cortex, deep grey matter nuclei and the spinal cord.
    Gilmore CP, Donaldson I, Bö L, Owens T, Lowe J, Evangelou N.
    J Neurol Neurosurg Psychiatry; 2009 Feb 15; 80(2):182-7. PubMed ID: 18829630
    [Abstract] [Full Text] [Related]

  • 4. The histopathology of grey matter demyelination in multiple sclerosis.
    Bø L.
    Acta Neurol Scand Suppl; 2009 Feb 15; (189):51-7. PubMed ID: 19566500
    [Abstract] [Full Text] [Related]

  • 5. Gray matter pathology in (chronic) MS: modern views on an early observation.
    Geurts JJ, Stys PK, Minagar A, Amor S, Zivadinov R.
    J Neurol Sci; 2009 Jul 15; 282(1-2):12-20. PubMed ID: 19249061
    [Abstract] [Full Text] [Related]

  • 6. Evidence for gray matter pathology in multiple sclerosis: a neuroimaging approach.
    Zivadinov R, Minagar A.
    J Neurol Sci; 2009 Jul 15; 282(1-2):1-4. PubMed ID: 19345379
    [Abstract] [Full Text] [Related]

  • 7. Gray matter damage in multiple sclerosis: Impact on clinical symptoms.
    van Munster CE, Jonkman LE, Weinstein HC, Uitdehaag BM, Geurts JJ.
    Neuroscience; 2015 Sep 10; 303():446-61. PubMed ID: 26164500
    [Abstract] [Full Text] [Related]

  • 8. Gray matter atrophy correlates with MS disability progression measured with MSFC but not EDSS.
    Rudick RA, Lee JC, Nakamura K, Fisher E.
    J Neurol Sci; 2009 Jul 15; 282(1-2):106-11. PubMed ID: 19100997
    [Abstract] [Full Text] [Related]

  • 9. Unraveling the relationship between regional gray matter atrophy and pathology in connected white matter tracts in long-standing multiple sclerosis.
    Steenwijk MD, Daams M, Pouwels PJ, J Balk L, Tewarie PK, Geurts JJ, Barkhof F, Vrenken H.
    Hum Brain Mapp; 2015 May 15; 36(5):1796-807. PubMed ID: 25627545
    [Abstract] [Full Text] [Related]

  • 10. Gray matter involvement in multiple sclerosis.
    Pirko I, Lucchinetti CF, Sriram S, Bakshi R.
    Neurology; 2007 Feb 27; 68(9):634-42. PubMed ID: 17325269
    [Abstract] [Full Text] [Related]

  • 11. White-matter lesions drive deep gray-matter atrophy in early multiple sclerosis: support from structural MRI.
    Mühlau M, Buck D, Förschler A, Boucard CC, Arsic M, Schmidt P, Gaser C, Berthele A, Hoshi M, Jochim A, Kronsbein H, Zimmer C, Hemmer B, Ilg R.
    Mult Scler; 2013 Oct 27; 19(11):1485-92. PubMed ID: 23462349
    [Abstract] [Full Text] [Related]

  • 12. Contribution of cortical and white matter lesions to cognitive impairment in multiple sclerosis.
    Papadopoulou A, Müller-Lenke N, Naegelin Y, Kalt G, Bendfeldt K, Kuster P, Stoecklin M, Gass A, Sprenger T, Radue EW, Kappos L, Penner IK.
    Mult Scler; 2013 Sep 27; 19(10):1290-6. PubMed ID: 23459568
    [Abstract] [Full Text] [Related]

  • 13. Increased cortical curvature reflects white matter atrophy in individual patients with early multiple sclerosis.
    Deppe M, Marinell J, Krämer J, Duning T, Ruck T, Simon OJ, Zipp F, Wiendl H, Meuth SG.
    Neuroimage Clin; 2014 Sep 27; 6():475-87. PubMed ID: 25610761
    [Abstract] [Full Text] [Related]

  • 14. Gray matter involvement in patients with multiple sclerosis as shown by magnetic resonance imaging.
    Rumzan R, Chen X, Li YM.
    Chin Med J (Engl); 2012 Jul 27; 125(13):2361-4. PubMed ID: 22882862
    [Abstract] [Full Text] [Related]

  • 15. Single scan quantitative gradient recalled echo MRI for evaluation of tissue damage in lesions and normal appearing gray and white matter in multiple sclerosis.
    Xiang B, Wen J, Cross AH, Yablonskiy DA.
    J Magn Reson Imaging; 2019 Feb 27; 49(2):487-498. PubMed ID: 30155934
    [Abstract] [Full Text] [Related]

  • 16. Increased cortical grey matter lesion detection in multiple sclerosis with 7 T MRI: a post-mortem verification study.
    Kilsdonk ID, Jonkman LE, Klaver R, van Veluw SJ, Zwanenburg JJ, Kuijer JP, Pouwels PJ, Twisk JW, Wattjes MP, Luijten PR, Barkhof F, Geurts JJ.
    Brain; 2016 May 27; 139(Pt 5):1472-81. PubMed ID: 26956422
    [Abstract] [Full Text] [Related]

  • 17. Lack of correlation between cortical demyelination and white matter pathologic changes in multiple sclerosis.
    Bö L, Geurts JJ, van der Valk P, Polman C, Barkhof F.
    Arch Neurol; 2007 Jan 27; 64(1):76-80. PubMed ID: 17210812
    [Abstract] [Full Text] [Related]

  • 18. Small heat shock proteins are induced during multiple sclerosis lesion development in white but not grey matter.
    Peferoen LA, Gerritsen WH, Breur M, Ummenthum KM, Peferoen-Baert RM, van der Valk P, van Noort JM, Amor S.
    Acta Neuropathol Commun; 2015 Dec 22; 3():87. PubMed ID: 26694816
    [Abstract] [Full Text] [Related]

  • 19. Gray matter atrophy in multiple sclerosis: a longitudinal study.
    Fisher E, Lee JC, Nakamura K, Rudick RA.
    Ann Neurol; 2008 Sep 22; 64(3):255-65. PubMed ID: 18661561
    [Abstract] [Full Text] [Related]

  • 20. MRI evaluation of grey matter atrophy and disease course in multiple sclerosis: an overview of current knowledge.
    Jacobsen CO, Farbu E.
    Acta Neurol Scand Suppl; 2014 Sep 22; (198):32-6. PubMed ID: 24588504
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.